Cite
Ezekowitz JA, Zheng Y, Cohen-Solal A, et al. Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA). Circulation. 2021;144(18):1489-1499doi: 10.1161/CIRCULATIONAHA.121.056797.
Ezekowitz, J. A., Zheng, Y., Cohen-Solal, A., Melenovský, V., Escobedo, J., Butler, J., Hernandez, A. F., Lam, C. S. P., O'Connor, C. M., Pieske, B., Ponikowski, P., Voors, A. A., deFilippi, C., Westerhout, C. M., McMullan, C., Roessig, L., & Armstrong, P. W. (2021). Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA). Circulation, 144(18), 1489-1499. https://doi.org/10.1161/CIRCULATIONAHA.121.056797
Ezekowitz, Justin A, et al. "Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)." Circulation vol. 144,18 (2021): 1489-1499. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056797
Ezekowitz JA, Zheng Y, Cohen-Solal A, Melenovský V, Escobedo J, Butler J, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Voors AA, deFilippi C, Westerhout CM, McMullan C, Roessig L, Armstrong PW. Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA). Circulation. 2021 Nov 02;144(18):1489-1499. doi: 10.1161/CIRCULATIONAHA.121.056797. Epub 2021 Aug 25. PMID: 34432985.
Copy
Download .nbib